Moreover, HIF-1α activation can alter metabolic pathways, promoting glycolysis and angiogenesis, which support tumor growth and survival in the hypoxic tumor microenvironment, leading to the progression of gastrointestinal cancers in individuals with obesity [70]. This evidence concerns the gene HIF1A and Obesity.